miR-18b attenuates cerebral ischemia/reperfusion injury through regulation of ANXA3 and PI3K/Akt signaling pathway.

In conclusion, these data indicate that miR-18b protects against cerebral I/R injury by inhibiting ANXA3 and activating PI3K/Akt pathway, which provides a promising therapeutic target for ischemic stroke therapy. PMID: 32380186 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32380186?dopt=Abstract

Source: Brain Research Bulletin - May 3, 2020 Category: Neurology Authors: Min XL, He M, Shi Y, Xie L, Ma XJ, Cao Y Tags: Brain Res Bull Source Type: research